Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.82%23.25B | 5.65%22.39B | -0.13%5.57B | 3.95%5.99B | 7.78%5.68B | 12.35%5.16B | 7.71%21.2B | 10.44%5.57B | 16.68%5.76B | 16.51%5.27B |
| Cost of revenue | -0.55%19.77B | 8.97%19.88B | 4.97%4.96B | 6.27%5.25B | 11.10%5.07B | 14.56%4.6B | 9.49%18.25B | 11.76%4.73B | 15.68%4.94B | 18.55%4.57B |
| Gross profit | 38.41%3.48B | -14.84%2.51B | -28.55%605.85M | -10.11%733.71M | -13.65%610.05M | -2.93%563.36M | -2.14%2.95B | 3.60%847.9M | 23.09%816.2M | 4.89%706.45M |
| Operating expense | 1.30%2.97B | 1.82%2.94B | 5.60%731.88M | 3.06%761.26M | -0.87%724.1M | -0.37%717.77M | 4.51%2.88B | -0.74%693.09M | 4.91%738.63M | 9.62%730.43M |
| Operating profit | 219.70%505.16M | -717.61%-422.04M | -181.41%-126.03M | -135.50%-27.54M | -375.63%-114.06M | -10.24%-154.41M | -73.42%68.33M | 28.76%154.81M | 289.57%77.57M | -431.86%-23.98M |
| Net non-operating interest income (expenses) | -18.31%-114.05M | -53.85%-96.4M | -59.71%-28.61M | -57.09%-26.49M | -40.89%-21.46M | -56.82%-19.85M | -20.04%-62.66M | -39.53%-17.91M | -35.24%-16.86M | -5.66%-15.23M |
| Non-operating interest income | 31.45%11.05M | 82.52%8.41M | 136.98%2.19M | 44.44%2.22M | 129.02%2.55M | 40.52%1.45M | 9.85%4.61M | 67.33%922K | 16.26%1.54M | -13.52%1.11M |
| Non-operating interest expense | 19.36%125.1M | 55.81%104.81M | 63.49%30.79M | 56.04%28.71M | 46.89%24.01M | 55.59%21.3M | 19.28%67.27M | 40.67%18.83M | 33.42%18.4M | 4.09%16.34M |
| Net investment income | -43.92%31.23M | 130.92%55.69M | 109.02%1.33M | -71.74%12.64M | 177.70%30.45M | 166.90%11.28M | 46.82%24.12M | 3.26%-14.71M | 269.17%44.72M | 336.16%10.97M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -26.57%165M | 224.7M | 0 | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 94.14%-6.77M | -284.07%-115.63M | -121.34%-51.92M | 79.69%-483K | -29.71%-5.54M | -57.69M | 35.37%-30.11M | 48.59%-23.46M | -666.19%-2.38M | -480.30%-4.27M |
| Less:Restructuring and mergern&acquisition | --0 | --50.84M | --21.56M | --239K | --164K | --28.88M | --0 | --0 | --0 | --0 |
| Less:Other special charges | -84.53%5.41M | 366.14%34.98M | -24.00%700K | -89.78%243K | --5.23M | --28.8M | -74.64%7.5M | -96.78%921K | 666.19%2.38M | ---- |
| Less:Write off | -95.43%1.36M | 31.87%29.81M | 31.62%29.66M | --1K | ---- | ---- | 33.00%22.6M | 32.61%22.54M | --0 | ---- |
| Other non-operating income (expenses) | -280.52%-25.73M | 125.89%14.25M | 590.02%7.6M | 137.67%1.05M | 101.24%788K | -52.52%4.81M | -8,204.37%-55.06M | -85.64%1.1M | -1,276.85%-2.8M | -3,870.61%-63.49M |
| Income before tax | 263.47%554.85M | -512.98%-339.42M | -72.87%27.08M | -140.72%-40.82M | -14.38%-109.82M | -35.38%-215.86M | -114.27%-55.37M | -62.77%99.83M | 344.18%100.26M | -577.93%-96.01M |
| Income tax | 400.97%101.96M | -283.55%-33.88M | -197.34%-80.05M | 4,889.87%49.25M | 96.60%-751K | 94.54%-2.33M | -77.06%18.46M | 71.36%82.24M | 127.32%987K | -3,132.78%-22.11M |
| Net income | 248.22%452.88M | -313.84%-305.54M | 509.19%107.13M | -190.73%-90.07M | -47.59%-109.07M | -82.84%-213.54M | -124.01%-73.83M | -92.01%17.59M | 365.11%99.27M | -396.23%-73.9M |
| Net income continuous operations | 248.22%452.89M | -313.84%-305.54M | 509.15%107.13M | -190.73%-90.07M | -47.58%-109.07M | -82.84%-213.54M | -124.01%-73.83M | -92.01%17.59M | 365.11%99.27M | -396.27%-73.9M |
| Noncontrolling interests | 0 | 0 | 0 | |||||||
| Net income attributable to the company | 248.22%452.88M | -313.84%-305.54M | 509.19%107.13M | -190.73%-90.07M | -47.59%-109.07M | -82.84%-213.54M | -124.01%-73.83M | -92.01%17.59M | 365.11%99.27M | -396.23%-73.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 248.22%452.88M | -313.84%-305.54M | 509.19%107.13M | -190.73%-90.07M | -47.59%-109.07M | -82.84%-213.54M | -124.01%-73.83M | -92.01%17.59M | 365.11%99.27M | -396.23%-73.9M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 248.24%129.43 | -313.79%-87.31 | 509.96%30.62 | -190.73%-25.74 | -47.59%-31.17 | -82.86%-61.02 | -124.01%-21.1 | -92.02%5.02 | 365.14%28.37 | -395.77%-21.12 |
| Diluted earnings per share | 248.24%129.43 | -313.79%-87.31 | 509.88%30.6161 | -190.75%-25.74 | -47.59%-31.17 | -82.86%-61.02 | -124.01%-21.1 | -92.02%5.02 | 365.08%28.3637 | -395.77%-21.12 |
| Dividend per share | 0.00%50 | 0.00%50 | 0.00%25 | 0 | 0.00%25 | 0 | 0.00%50 | 0.00%25 | 0 | 0.00%25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |